1. Home
  2. People
  3. Cherry, Travis

Travis Cherry

Senior Associate

New York

Travis Cherry is a senior associate in Orrick's New York office and a member of the Capital Markets Group.

Travis advises companies and underwriters on a broad range of capital markets transactions, including offerings of equity and debt securities, going public transactions, including initial public offerings and de-SPAC transactions, securities law compliance and corporate governance issues.

  • Prior to joining Orrick, Travis was an associate in the New York office of Akin Gump Strauss Hauer & Feld LLP.

  • Recent engagements include:

    • Pasqal in its $2 billion business combination with Bleichroader Acquisition Corp. II, a SPAC led and backed by Michel Combes and Andrew Gundlach
    • Oklo Inc. in its $1.5 billion at-the-market offering
    • Crown PropTech Acquisitions, a special purpose acquisition company, in its pending business combination with Lancaster Exploration Limited and Mkango Polksa
    • Aptean in its take-private acquisition of Logility Supply Chain Solutions
    • ANI Pharmaceuticals, Inc. in its underwritten public offering of common stock
    • Fisker Inc. in its issuance of up to $1.13 billion of 0% senior convertible notes to an institutional investor in a registered direct offering
    • BuzzFeed, Inc. (f/k/a 890 5th Avenue Partners, Inc.) in connection with its issuance of $150 million of senior convertible notes
    • CIIG Capital Partners II, a special purpose acquisition company, in its $573 million merger with Zapp Electric Vehicles
    • COVA Acquisition Corp. in its $3.8 billion business combination with ECARX Holdings, Inc.
    • ANI Pharmaceuticals, Inc. in its acquisition of Novitium Pharma LLC
    • Various direct and alternative lending funds relating to debt arrangements by such entities
    • Surf Air Mobility Inc. in connection with its term loan financing
    • 890 5th Avenue Partners, Inc., a special purpose acquisition company, in its $1.5 billion merger with BuzzFeed
    • Starboard Value Acquisition Corp. in its $3.4 billion merger with Cyxtera Technologies, Inc. and related $250 million common stock PIPE financing*
    • CIIG Merger Corp., a special purpose acquisition company, in its $5.4 billion merger with Arrival*
    • Vanda Pharmaceuticals Inc. in its adoption of a limited duration stockholder rights plan
    • Keyarch Acquisition Corp., a special purpose acquisition company, in its $115 million initial public offering
    • Underwriters in the $200 million initial public offering of Waverley Capital Acquisition*
    • Starboard Value Acquisition Corp., a special purpose acquisition company, in its $404.2 million initial public offering*

    *Matter handled prior to joining Orrick

Insights

News